Page 9 - David Joyner News Today

Here is a selection of recent executive hires, departures and layoffs occurring across the healthcare industry.

CVS earnings call for the period ending December 31, 2022.

Some instructors seek to craft assignments that guide students in surpassing what AI can do. Others see that as a fool’s errand—one that lends too much agency to the software.

The Aeson implant maker, which targets a U.S. launch in 2026, plans to lift its production to 100 hearts in 2023 and further accelerate to 500 in 2024 and 1,000 in 2027. Evidence of 'genocide' among Brazil's indigenous Yanomami, says minister Following reports of indigenous Yanomami children dying in Brazil of malnutrition and other diseases caused by illegal gold mining, there is strong evidence of "genocide," the country's Justice Minister Flavio Dino said on Monday...

/PRNewswire/ -- CVS Health® (NYSE: CVS) today announced two executive appointments. David Joyner will rejoin the company as Executive Vice President and...

By Kathryn Hardison CVS Health Corp. has appointed a new head of pharmacy services as part of its recent executive changes. The company said Monday that David Joyner will rejoin the... | January 23, 2023

The new European Cancer Imaging Initiative will give clinicians, researchers and innovators "easy access to large amounts of cancer imaging data", the European Commission said in a statement. CVS names new pharmacy services, consumer product chiefs CVS Health Corp said on Monday that David Joyner would return to head the U.S. diversified healthcare company's pharmacy services and tapped former Cigna Corp executive Amy Bricker as its chief product officer for consumer business.

/PRNewswire/ -- Canopy Health is pleased to announce the addition of St. Rose Hospital (Hayward) to its network alliance effective January 1, 2023. St. Rose...

/PRNewswire/ -- Hill Physicians Medical Group (HPMG), the largest independent physician group in Northern California, has been honored as a top performer by...

A new Peacock docuseries takes a look at one of public television’s most divisive endeavors.